Subunit vaccine efficacy against Botulinum neurotoxin subtypes. - Wikidata - awgldk - TriplyDB

Subunit vaccine efficacy against Botulinum neurotoxin subtypes.

Subunit vaccine efficacy against Botulinum neurotoxin subtypes.

http://www.wikidata.org/entity/Q35532054

about

Botulinum neurotoxins A and E undergo retrograde axonal transport in primary motor neurons What next for botulism vaccine development?Production and evaluation of a recombinant chimeric vaccine against clostridium botulinum neurotoxin types C and D.Cargo-delivery platforms for targeted delivery of inhibitor cargos against botulism.DNA electroporation in rabbits as a method for generation of high-titer neutralizing antisera: examples of the botulinum toxins types A, B, and E A mutated recombinant subunit vaccine protects mice and guinea pigs against botulinum type A intoxication.Protein Structure Facilitates High-Resolution Immunological Mapping.The Light Chain Defines the Duration of Action of Botulinum Toxin Serotype A Subtypes.

P2860

Q27339199-4874B8FC-574D-48B8-853C-91E83CDFBEA9 Q34343808-B7978DDB-849A-46BA-B197-119168D9EB79 Q34920929-46C38212-2962-49C2-AB08-886817710192 Q35542237-E5481E9B-9F20-475D-9110-E454374B55BF Q37530489-E9374338-C1D8-47E8-A778-E57DCDC9DED5 Q46415592-118B5274-9E79-4961-B7D0-AEC7064FCAF7 Q47098544-37328AA4-AA4A-4A34-AE24-78D2837AC727 Q52626788-3A41D18E-F2D7-4F0D-A7C6-7656B04C7EAE

P2860

Subunit vaccine efficacy against Botulinum neurotoxin subtypes.

http://www.wikidata.org/entity/Q35532054

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Subunit vaccine efficacy against Botulinum neurotoxin subtypes.

@ast

Subunit vaccine efficacy against Botulinum neurotoxin subtypes.

@en

type

label

Subunit vaccine efficacy against Botulinum neurotoxin subtypes.

@ast

Subunit vaccine efficacy against Botulinum neurotoxin subtypes.

@en

prefLabel

Subunit vaccine efficacy against Botulinum neurotoxin subtypes.

@ast

Subunit vaccine efficacy against Botulinum neurotoxin subtypes.

@en

P1433

Q35532054-8572A23C-0CC9-47FB-8278-A715421B9EA6

P1476

Q35532054-72A96C8C-29EA-4A06-ADE5-DA3A4DDCEB0F

P2093

Q35532054-3428AA54-2C65-4B8C-8EC0-81E61D8E3AF6

Q35532054-5D2E2E87-1BDD-4873-B5CA-47B0190ACC42

Q35532054-67CA6277-98C4-4233-9FEE-0738B4F971A9

Q35532054-A9DD7E32-20B7-4A9E-9190-2AEBDB370E29

Q35532054-AAC0237C-765D-4C4A-BF40-57FFE293064A

Q35532054-BE5260C8-FD41-432F-B59D-10D0D67719EC

P2860

Q35532054-0367F4AA-B351-41C1-96B6-F2661C329345

Q35532054-0C3DFF62-CE76-447E-824C-95ACEFF44F7E

Q35532054-219B57BC-3E7A-42D4-9AB8-DE9532D0C1D3

Q35532054-2653CD48-5825-4143-BDE4-27DAE7AA332D

Q35532054-2BB4870D-B02A-4DC0-84A5-17EAD51A7D7B

Q35532054-2D74F004-9D77-4777-99EC-DCCBB2DF3CD0

Q35532054-2F982018-7D1F-446D-B525-696933399B45

Q35532054-30A34EE0-FD14-49EF-81D2-7214FF13D707

Q35532054-3A8500D4-0718-4EEF-9D4E-B5F18E0DDF12

Q35532054-3F81DC84-D1AD-4281-BC4A-A07BC70FD6C1

P304

Q35532054-0C6ED9EF-4412-4858-9D59-3CD143CD4943

P31

Q35532054-8C37D865-3B60-4A07-8902-CE8D7D5E9C76

P356

Q35532054-12A0FE10-322F-4DA1-8129-980EADBBB55F

P407

Q35532054-258608E2-01D1-4E28-82CF-7122F29BB7EF

P433

Q35532054-E950E5AE-0F75-48A2-B09C-53EFCB4DCCB8

P478

Q35532054-C5574128-DBA6-4A50-91C6-FBCA3146319C

P577

Q35532054-5C14A1BA-1926-42C7-A8E3-995C74F0BD7E

P5875

Q35532054-2768931A-979A-4508-885F-9DCD0814D115

P698

Q35532054-EF94DFAF-70F3-402D-85ED-0F4691DA9090

P932

Q35532054-74C799F2-0C1F-4D37-A63E-857FDFE09088

P356

J.VACCINE.2011.07.134

P1433

P1476

Subunit vaccine efficacy against Botulinum neurotoxin subtypes.

@en

P2093

Amanda Przedpelski

http://www.w3.org/2001/XMLSchema#string

Eric A Johnson

http://www.w3.org/2001/XMLSchema#string

James S Henkel

http://www.w3.org/2001/XMLSchema#string

Joseph T Barbieri

http://www.w3.org/2001/XMLSchema#string

Robert B Fritz

http://www.w3.org/2001/XMLSchema#string

William H Tepp

http://www.w3.org/2001/XMLSchema#string

P2860

Bacterial toxins: a table of lethal amounts

Pathema: a clade-specific bioinformatics resource center for pathogen research

Synapsin I (protein I), a nerve terminal-specific phosphoprotein. III. Its association with synaptic vesicles studied in a highly purified synaptic vesicle preparation

Crystal Structure of Botulinum Neurotoxin Type A in Complex with the Cell Surface Co-Receptor GT1b—Insight into the Toxin–Neuron Interaction

Glycosylated SV2 and Gangliosides as Dual Receptors for Botulinum Neurotoxin Serotype F

The HCC-domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction.

Expression of the Clostridium botulinum A2 neurotoxin gene cluster proteins and characterization of the A2 complex.

Purification, potency, and efficacy of the botulinum neurotoxin type A binding domain from Pichia pastoris as a recombinant vaccine candidate.

Characterization of the antibody response to the receptor binding domain of botulinum neurotoxin serotypes A and E.

Development of vaccines for prevention of botulism.

P304

7688-7695

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.VACCINE.2011.07.134

http://www.w3.org/2001/XMLSchema#string

P407

P433

44

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51569044

http://www.w3.org/2001/XMLSchema#string

P698

21839134

http://www.w3.org/2001/XMLSchema#string

P932

3209516

http://www.w3.org/2001/XMLSchema#string